MeVO: To Treat or Not To Treat? Review of the Latest Evidence
Ossama Yassin Mansour, Ahmed Ossama, Nada Nasr, Eman Hamdy, Faisal Alghamdi, Nadia Hammami · 2026
Read MeVO: To Treat or Not To Treat? Review of the Latest Evidence by Ossama Yassin Mansour, Ahmed Ossama, Nada Nasr, Eman Hamdy, Faisal Alghamdi, Nadia Hammami (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13588861.txt.
Description
Ossama Yassin Mansour and co-authors review, in a 2026 paper, whether clot removal by catheter should extend to medium sized brain vessels in stroke. For large vessel blockages, the procedure is standard care. Medium vessel cases are contested, since the vessels are smaller and the gains less sure.
Three trials found no functional benefit from adding the procedure to medical care, with more bleeding and serious harms. One trial limited to stronger deficits within 24 hours did find more independence with treatment. A regional registry of 164 patients matched trial level results, with good reopening rates and low symptomatic bleeding. A dedicated smaller device also reopened vessels cleanly in its trial. Costs, though, ran above regional value thresholds. The authors conclude routine use is unjustified. Benefit concentrates where deficits are moderate to severe, the tissue is eloquent, salvageable brain remains, and the blockage is reachable.
Catalog record
| CREATOR | Ossama Yassin Mansour, Ahmed Ossama, Nada Nasr, Eman Hamdy, Faisal Alghamdi, Nadia Hammami |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |